Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Short Interest Down 72.7% in May

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,804,605 shares, a decline of 72.7% from the April 30th total of 6,612,971 shares. Based on an average trading volume of 1,881,607 shares, the short-interest ratio is currently 1.0 days. Currently, 0.3% of the shares of the stock are short sold.

Curaleaf Stock Performance

Shares of CURLF stock opened at $3.51 on Friday. The business’s 50-day moving average price is $2.97 and its 200-day moving average price is $2.68. Curaleaf has a 12 month low of $0.72 and a 12 month high of $5.05. The firm has a market capitalization of $2.45 billion, a price-to-earnings ratio of -26.96 and a beta of 1.58. The company has a current ratio of 1.56, a quick ratio of 0.74 and a debt-to-equity ratio of 1.05.

Curaleaf’s stock is scheduled to reverse split before the market opens on Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, June 4th.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.17. The company had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. Equities research analysts forecast that Curaleaf will post -0.1 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to data from MarketBeat, Curaleaf has a consensus rating of “Strong Buy”.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.